Co‐Mutation of ASXL1 and KRAS Defines a Novel Ultra‐Adverse‐Risk Subtype of Acute Myeloid Leukemia in a Large‐Scale Cohort

ABSTRACT Background ASXL1 mutation acute myeloid leukemia represents a clinically aggressive subtype with heterogeneous outcomes. Current evidence remains inconclusive regarding the prognostic relevance of the KRAS mutation partner in AML with ASXL1 mutation. The comprehensive mutational landscape a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yijing Zhao, Ting Zhao, Feifei Tang, Xiaodong Mo, Yingjun Chang, Xiaosu Zhao, Lanping Xu, Yu Wang, Xiaohui Zhang, Hao Jiang, Qian Jiang, Xiaojun Huang, Yuqian Sun
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-03-01
Colecção:	Cancer Medicine
Assuntos:	acute myeloid leukemia ASXL1 mutations KRAS mutations prognosis relapse
Acesso em linha:	https://doi.org/10.1002/cam4.71715
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!